About MDDX
MDDX is a Healthcare company based in Newark (United States) founded in 2008, and was acquired by Clario in November 2017. Biomedical data collection software. Its chief executive, as recorded, is David Herron. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Curebase, L7 Informatics and Clinical Research IO; 3 of its 3 listed competitors have raised funding.
Company details
MDDX was founded in 2008 in Newark, United States, as a provider of biomedical data collection software focused on the medical imaging sector. Cloud-based image submission technology was developed by the company, which ensured FDA 21 CFR Part 11 compliance. Following acquisition by Bioclinica, the platform was integrated into the SMART solution suite, supporting centralized services for image receipt, analysis, management, reporting, and regulatory submission across clinical operations.
Funding Insights of MDDX
- Total Rounds 2
- Last Round Grant — $399,972
- First Round $299,998
(Sep 2020)
- Investors Count 1
All 2 funding rounds of MDDX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in MDDX
MDDX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Clario.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
CRO focused on providing clinical trial supply services for biopharma sector | 1972 | clario.com | Philadelphia, United States |
Investor details for MDDX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MDDX
1 people are tracked at MDDX (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Herron | CEO & President | Leadership |
Complete people profiles for MDDX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MDDX
4 dated milestones of MDDX across 13 years, from founding to its latest funding, stage changes and deals.
- Founded MDDX is founded.
- Exit Acquired by Clario.
- Funding First funding round of $300K.
- Funding Latest funding round, Grant, of $400K.
Competitors of MDDX
MDDX has 3 listed competitors in our database, 3 of them funded. They include Curebase, L7 Informatics and Clinical Research IO.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| curebase.com | 2017 | San Francisco, United States | $59.01M | 94 | Patient enrollment platform for decentralized clinical research is provided. | |
| l7informatics.com | 2012 | Austin, United States | $54.97M | 126 | Clinical trial workflow management software is provided for laboratories. | |
| clinicalresearch.io | 2015 | Boston, United States | $16.7M | 16 | Clinical trial management software is provided for research sites. |
Detailed competitors of MDDX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as MDDX (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mddx
Complete news archive for MDDX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MDDX
MDDX was founded in 2008 and raised its 1st funding round 12 years after it was founded.
MDDX is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
David Herron is the CEO of MDDX, as recorded in our data.
MDDX was founded in 2008 in Newark, United States, as a provider of biomedical data collection software focused on the medical imaging sector. Cloud-based image submission technology was developed by the company, which ensured FDA 21 CFR Part 11 compliance. Following acquisition by Bioclinica, the platform was integrated into the SMART solution suite, supporting centralized services for image receipt, analysis, management, reporting, and regulatory submission across clinical operations.
MDDX's top competitors include L7 Informatics, Curebase and Clinical Research IO.
Yes. MDDX was acquired by Clario in November 2017.